Studies have shown that FOS stimulated the production of CD4 and CD8 cells, which indicates that it could act as an immunostimulatory agent in endotoxemia and, therefore improve immunocompetence [60,61]. The gene discussed is CD8A; the disease is serum lipopolysaccharide activity.